Predictive Factors Correlated with the Development of Immune-Related Adverse Events in Patients with Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors.
Kei SoneharaKazunari TateishiTaisuke ArakiMasamichi KomatsuJumpei AkahaneHiroshi YamamotoMasayuki HanaokaPublished in: Cancer management and research (2022)
The present study revealed that lines of immunotherapy and LIPI were correlated with the development of irAEs in NSCLC patients who received ICIs and can help clinicians who manage patients experiencing irAEs receiving ICIs.